315 related articles for article (PubMed ID: 1679712)
1. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
Muraoka S
Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
[TBL] [Abstract][Full Text] [Related]
2. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
3. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
4. Recognition by cytotoxic T lymphocytes of Qa-2 antigens. Sensitivity of Qa-2 molecules to phosphatidylinositol-specific phospholipase C.
Mann D; Forman J
J Immunol; 1988 Sep; 141(6):1813-8. PubMed ID: 2459191
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the cytotoxic T lymphocyte response against Qa-1 alloantigens.
Cassell DJ; Forman J
J Immunol; 1990 Jun; 144(11):4075-81. PubMed ID: 2140385
[TBL] [Abstract][Full Text] [Related]
6. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
Lustgarten J; Waks T; Eshhar Z
Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
[TBL] [Abstract][Full Text] [Related]
7. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells.
Pilarski LM; Carayanniotis G
J Immunol; 1985 Dec; 135(6):3686-90. PubMed ID: 2415580
[TBL] [Abstract][Full Text] [Related]
8. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
Yang HY; Dundon PL; Nahill SR; Welsh RM
J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
[TBL] [Abstract][Full Text] [Related]
10. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
Kern DE; Klarnet JP; Jensen MC; Greenberg PD
J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
[TBL] [Abstract][Full Text] [Related]
11. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
[TBL] [Abstract][Full Text] [Related]
12. Generation of hen egg lysozyme-specific and major histocompatibility complex class I-restricted cytolytic T lymphocytes: recognition of cytosolic and secreted antigen expressed by transfected cells.
Forquet F; Calin V; Trescol-Biemont MC; Kanellopoulos J; Mottez E; Kourilsky P; Rabourdin-Combe C; Gerlier D
Eur J Immunol; 1990 Oct; 20(10):2325-32. PubMed ID: 2242761
[TBL] [Abstract][Full Text] [Related]
13. Qa-1/Tla region alloantigen-specific CTL with alpha beta receptor.
Germana S; Shinohara N
Immunology; 1991 Dec; 74(4):578-82. PubMed ID: 1838350
[TBL] [Abstract][Full Text] [Related]
14. The Q7 alpha 3 domain alters T cell recognition of class I antigens.
Aldrich CJ; Lowen LC; Mann D; Nishimura M; Hood L; Stroynowski I; Forman J
J Immunol; 1991 May; 146(9):3082-90. PubMed ID: 1849941
[TBL] [Abstract][Full Text] [Related]
15. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
Suzuki R; Suzuki S; Ebina N; Kumagai K
J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a CD4(L3T4)-positive cytotoxic T cell clone that is restricted by class I major histocompatibility complex antigen on FBL-3 tumor cell.
Matsubayashi Y; Zenita K; Morioka A; Iwashiro M; Masuda T; Uchino H; Fujita T; Kuribayashi K
Immunobiology; 1989 Nov; 180(1):33-46. PubMed ID: 2483152
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T lymphocyte recognition of a xenogeneic major histocompatibility complex antigen expressed in transgenic mice.
Bluestone JA; Pescovitz MD; Frels WI; Singer DS; Hodes RJ
Eur J Immunol; 1987 Jul; 17(7):1035-41. PubMed ID: 2440691
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD4 can confer major histocompatibility complex class II-associated superantigen reactivity upon a T cell receptor derived from a CD8-dependent cytotoxic T lymphocyte clone.
Wallace VA; Ohashi PS; Hengartner H; Mak TW
Eur J Immunol; 1990 Nov; 20(11):2471-7. PubMed ID: 2123792
[TBL] [Abstract][Full Text] [Related]
19. Masking of veto function in vivo by activated CD4+ T lymphocytes.
Rammensee HG; Hügin D
Eur J Immunol; 1989 Apr; 19(4):643-8. PubMed ID: 2567242
[TBL] [Abstract][Full Text] [Related]
20. Specific suppression of antibody responses by soluble protein-specific, class II-restricted cytolytic T lymphocyte clones.
Shinohara N; Huang YY; Muroyama A
Eur J Immunol; 1991 Jan; 21(1):23-7. PubMed ID: 1991488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
